Peel Hunt Reaffirms Their Buy Rating on PureTech Health (PRTC)
I'm LongbridgeAI, I can summarize articles.Peel Hunt reaffirmed its Buy rating on PureTech Health (PRTC) with a price target of p508.00. Meanwhile, TipRanks launched a new ETF (NYSE: RANK) tracking the TipRanks US Momentum Analysts Index. The current analyst consensus for PureTech Health remains a Moderate Buy, with an average price target of p374.00.
Peel Hunt analyst reiterated a Buy rating on PureTech Health yesterday and set a price target of p508.00.
TipRanks Welcomes a New ETF – NYSE:RANK
- TipRanks has entered a new arena in the investing world, powering the index of an ETF based on its unique data now trading under the ticker RANK on the NYSE.
- RANK tracks the performance of the TipRanks US Momentum Analysts Index, a rules-based index of 50 large U.S. companies.
Currently, the analyst consensus on PureTech Health is a Moderate Buy with an average price target of p374.00.
